AstraZeneca’s Truqap Flops in Phase III Triple-Negative Breast Cancer Trial 6/18/2024

Merck Wins FDA Approval for First Pneumococcal Vaccine Designed for Adults 6/18/2024

GSK Reignites Blenrep Blockbuster Aspirations With Data from Phase III Studies 6/18/2024

Roche Inks Potential $1.8B Deal With Ascidian to Develop RNA Exon Therapies 6/18/2024

Decheng Capital Eyes $700M Raise for Fifth Life Sciences Fund as VC Heats Up 6/18/2024

FDA Slaps BioNTech-MediLink ADC With Partial Clinical Hold Due to ‘Significant Risk of Illness’ 6/17/2024

Takeda’s Epilepsy Drug Stumbles in Back-to-Back Phase III Rare Disease Failures 6/17/2024

Gilead’s Magrolimab Ineffective, Linked to Increase Risk of Death in MDS Patients 6/17/2024

AstraZeneca’s Imfinzi Gets FDA Approval for Treating Endometrial Cancer 6/17/2024

Novo Nordisk CEO Agrees to Testify at Senate Hearing After Sanders’ Subpoena Threat 6/17/2024

J&J’s $6.5B Momenta Buy Pays Off With Phase II Sjögren’s Disease Win 6/17/2024

Genetic Therapies Show Early Promise in Treating Obesity 6/17/2024

AI Enables Individualized Cancer Vaccines 6/17/2024

FDA Action Alert: Merck, BMS, Sarepta and More 6/17/2024

Opinion: Regulatory Flexibility Can Accelerate Rare Disease Drug Development 6/17/2024

Telix Abandons IPO Plans at Last Minute, Cites ‘Current Market Conditions’ 6/14/2024

J.P. Morgan Raises Over $500M for First Biotech Venture Capital Fund 6/14/2024

SCOTUS Upholds Access to Abortion Pill, Pharma Industry Applauds Court’s Ruling 6/14/2024

GLP-1 Global Obesity Market to Reach $111B by 2033, Despite Headwinds: GlobalData 6/14/2024

With Donanemab on the Cusp of Approval, Proper Alzheimer’s Diagnosis Is Urgent 6/14/2024